expert reaction to MHRA update on the PATHWAYS clinical trial, that a modified protocol has been agreed by the MHRA as meeting the required regulatory standards... (opens in new tab)

Scientists comment on an update from the Medicines and Healthcare Products Regulatory Agency (MHRA) on the PATHWAYS trial of puberty suppression in gender incongruence.